{"entity":{"type":"insider","cik":"0001857670","url":"/insider/0001857670","json_url":"/insider/0001857670.json","name":"Curley Joanne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":18,"first":"2022-06-02","last":"2023-08-23","span_basis":"filed_date"},"name_variants":[{"name":"Curley Joanne","source":"filing","n_filings":18,"first_seen":"2022-06-02","last_seen":"2023-08-23"}],"transactions":[{"id":7954608,"accession":"0001209191-23-047103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047103","line_url":"/filing/0001209191-23-047103#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1490.0,"shares_display":"1,490","price_per_share":16.6558,"price_display":"16.66","price_state":"stated","total_value":24817.142,"total_display":"24,817.14","total_whole":"24,817","shares_owned_after":26962.0,"shares_owned_after_display":"26,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":6827062,"accession":"0001209191-22-061973","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-061973","line_url":"/filing/0001209191-22-061973","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2212.0,"shares_display":"2,212","price_per_share":19.491829430379745,"price_display":"19.49","price_state":"stated","total_value":43115.9267,"total_display":"43,115.93","total_whole":"43,116","shares_owned_after":26821.0,"shares_owned_after_display":"26,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider","n_lines":2},{"id":6575366,"accession":"0001209191-22-061178","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-061178","line_url":"/filing/0001209191-22-061178","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12811.0,"shares_display":"12,811","price_per_share":18.269404503941924,"price_display":"18.27","price_state":"stated","total_value":234049.3411,"total_display":"234,049.34","total_whole":"234,049","shares_owned_after":26821.0,"shares_owned_after_display":"26,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-14","scope":"insider","n_lines":2},{"id":6575355,"accession":"0001209191-22-061178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-061178","line_url":"/filing/0001209191-22-061178#line-2","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":18.2498,"price_display":"18.25","price_state":"stated","total_value":125923.62,"total_display":"125,923.62","total_whole":"125,924","shares_owned_after":26821.0,"shares_owned_after_display":"26,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-14","scope":"insider"},{"id":6673830,"accession":"0001209191-22-060331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-060331","line_url":"/filing/0001209191-22-060331#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":494.0,"shares_display":"494","price_per_share":16.47,"price_display":"16.47","price_state":"stated","total_value":8136.18,"total_display":"8,136.18","total_whole":"8,136","shares_owned_after":26821.0,"shares_owned_after_display":"26,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-07","filed_date":"2022-12-08","scope":"insider"},{"id":6465993,"accession":"0001209191-22-058095","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-058095","line_url":"/filing/0001209191-22-058095","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3289.0,"shares_display":"3,289","price_per_share":15.849171906354515,"price_display":"15.85","price_state":"stated","total_value":52127.9264,"total_display":"52,127.93","total_whole":"52,128","shares_owned_after":27315.0,"shares_owned_after_display":"27,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider","n_lines":2},{"id":6673595,"accession":"0001209191-22-056364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-056364","line_url":"/filing/0001209191-22-056364#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":494.0,"shares_display":"494","price_per_share":16.54,"price_display":"16.54","price_state":"stated","total_value":8170.76,"total_display":"8,170.76","total_whole":"8,171","shares_owned_after":27315.0,"shares_owned_after_display":"27,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-11-10","scope":"insider"},{"id":6613741,"accession":"0001209191-22-054192","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-054192","line_url":"/filing/0001209191-22-054192","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8590.0,"shares_display":"8,590","price_per_share":19.41035476135041,"price_display":"19.41","price_state":"stated","total_value":166734.9474,"total_display":"166,734.95","total_whole":"166,735","shares_owned_after":27809.0,"shares_owned_after_display":"27,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider","n_lines":4},{"id":6457498,"accession":"0001209191-22-052972","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052972","line_url":"/filing/0001209191-22-052972#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":988.0,"shares_display":"988","price_per_share":21.64,"price_display":"21.64","price_state":"stated","total_value":21380.32,"total_display":"21,380.32","total_whole":"21,380","shares_owned_after":27809.0,"shares_owned_after_display":"27,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-06","scope":"insider"},{"id":6330941,"accession":"0001209191-22-051002","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-22-051002","line_url":"/filing/0001209191-22-051002","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1174.0,"shares_display":"1,174","price_per_share":21.400068994889267,"price_display":"21.40","price_state":"stated","total_value":25123.681,"total_display":"25,123.68","total_whole":"25,124","shares_owned_after":28797.0,"shares_owned_after_display":"28,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-22","scope":"insider","n_lines":2},{"id":6330929,"accession":"0001209191-22-051002","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-22-051002","line_url":"/filing/0001209191-22-051002","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15666.0,"shares_display":"15,666","price_per_share":20.67026014298481,"price_display":"20.67","price_state":"stated","total_value":323820.2954,"total_display":"323,820.30","total_whole":"323,820","shares_owned_after":28797.0,"shares_owned_after_display":"28,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2022-09-22","scope":"insider","n_lines":6},{"id":6753621,"accession":"0001209191-22-049176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-049176","line_url":"/filing/0001209191-22-049176#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":988.0,"shares_display":"988","price_per_share":18.63,"price_display":"18.63","price_state":"stated","total_value":18406.44,"total_display":"18,406.44","total_whole":"18,406","shares_owned_after":28797.0,"shares_owned_after_display":"28,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-08","scope":"insider"},{"id":6987210,"accession":"0001209191-22-047172","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-22-047172","line_url":"/filing/0001209191-22-047172","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1630.0,"shares_display":"1,630","price_per_share":18.873768711656442,"price_display":"18.87","price_state":"stated","total_value":30764.243,"total_display":"30,764.24","total_whole":"30,764","shares_owned_after":29785.0,"shares_owned_after_display":"29,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-23","scope":"insider","n_lines":2},{"id":6987203,"accession":"0001209191-22-047172","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-22-047172","line_url":"/filing/0001209191-22-047172","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6909.0,"shares_display":"6,909","price_per_share":19.195950369083803,"price_display":"19.20","price_state":"stated","total_value":132624.8211,"total_display":"132,624.82","total_whole":"132,625","shares_owned_after":29785.0,"shares_owned_after_display":"29,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-23","scope":"insider","n_lines":6},{"id":6672581,"accession":"0001209191-22-044412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044412","line_url":"/filing/0001209191-22-044412#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":988.0,"shares_display":"988","price_per_share":16.81,"price_display":"16.81","price_state":"stated","total_value":16608.28,"total_display":"16,608.28","total_whole":"16,608","shares_owned_after":17285.0,"shares_owned_after_display":"17,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-03","filed_date":"2022-08-04","scope":"insider"},{"id":6824819,"accession":"0001209191-22-042675","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-042675","line_url":"/filing/0001209191-22-042675","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11444.0,"shares_display":"11,444","price_per_share":16.014600926249564,"price_display":"16.01","price_state":"stated","total_value":183271.093,"total_display":"183,271.09","total_whole":"183,271","shares_owned_after":18273.0,"shares_owned_after_display":"18,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-20","scope":"insider","n_lines":4},{"id":6149072,"accession":"0001209191-22-042255","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-042255","line_url":"/filing/0001209191-22-042255","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9104.0,"shares_display":"9,104","price_per_share":15.143202306678383,"price_display":"15.14","price_state":"stated","total_value":137863.7138,"total_display":"137,863.71","total_whole":"137,864","shares_owned_after":21023.0,"shares_owned_after_display":"21,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-14","filed_date":"2022-07-15","scope":"insider","n_lines":2},{"id":6728943,"accession":"0001209191-22-041771","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-041771","line_url":"/filing/0001209191-22-041771","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9666.0,"shares_display":"9,666","price_per_share":15.047940047589488,"price_display":"15.05","price_state":"stated","total_value":145453.3885,"total_display":"145,453.39","total_whole":"145,453","shares_owned_after":23688.0,"shares_owned_after_display":"23,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-07","filed_date":"2022-07-11","scope":"insider","n_lines":3},{"id":6657071,"accession":"0001209191-22-039055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-039055","line_url":"/filing/0001209191-22-039055","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1545.0,"shares_display":"1,545","price_per_share":15.014856504854368,"price_display":"15.01","price_state":"stated","total_value":23197.9533,"total_display":"23,197.95","total_whole":"23,198","shares_owned_after":23994.0,"shares_owned_after_display":"23,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-22","filed_date":"2022-06-23","scope":"insider","n_lines":2},{"id":6925545,"accession":"0001209191-22-038582","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-038582","line_url":"/filing/0001209191-22-038582","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5887.0,"shares_display":"5,887","price_per_share":15.044248122982843,"price_display":"15.04","price_state":"stated","total_value":88565.4887,"total_display":"88,565.49","total_whole":"88,565","shares_owned_after":25194.0,"shares_owned_after_display":"25,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider","n_lines":3},{"id":6752578,"accession":"0001209191-22-033485","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-033485","line_url":"/filing/0001209191-22-033485#line-2","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001857670","owner_name":"Curley Joanne","owner_display_name":"Curley Joanne","owner_url":"/insider/0001857670","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":15.2155,"price_display":"15.22","price_state":"stated","total_value":6086.2,"total_display":"6,086.20","total_whole":"6,086","shares_owned_after":25194.0,"shares_owned_after_display":"25,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831828","name":"Vera Therapeutics, Inc.","url":"/issuer/0001831828","role":"Officer (Chief Development Officer)","n_filings":18,"first_seen":"2022-06-02","last_seen":"2023-08-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001857670","retrieved_at":"2026-08-26T12:04:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}